CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 90,621	$ 37,876
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	103,790	99,529
Change in fair value of derivative instruments	4	2
Amortization of deferred losses on derivative instruments	7,222	9,720
Write-downs and other charges, net	3,375	18,957
Goodwill impairment of Fertitta Interactive	0	5,562
Asset Impairment	2,101	27,687
Amortization of debt discount and debt issuance costs	13,897	13,178
Interest - paid in kind	3,176	3,097
Share-based compensation	2,038	2,286
Earnings (losses) from joint ventures	(1,070)	(754)
Distributions from joint ventures	1,314	1,291
Loss on extinguishment of debt	0	4,132
Gains on Native American Development	0	(49,074)
Changes in assets and liabilities:
Receivables, net	2,112	2,331
Inventories and prepaid expenses	(3,510)	(1,509)
Accounts payable	(1,401)	958
Accrued interest payable	(10,949)	(10,569)
Other accrued liabilities	10,876	3,381
Other, net	2,341	2,030
Net cash provided by operating activities	225,937	170,111
Cash flows from investing activities:
Capital expenditures, net of related payables	(74,376)	(71,526)
Proceeds from asset sales	25,156	791
Investments in joint ventures	(41)	(4,386)
Distributions in excess of earnings from joint ventures	845	785
Proceeds from repayment of Native American development costs	0	66,048
Native American development costs	(1,569)	(2,052)
Other, net	(1,882)	409
Net cash used in investing activities	(51,867)	(9,931)
Cash flows from financing activities:
Borrowings under credit agreements with original maturities of three months or less, net	45,000	0
Payments under credit agreements with original maturities greater than three months	(75,768)	(63,218)
Distributions to members and noncontrolling interests	(155,139)	(125,803)
Payment of debt issuance costs	0	(2,454)
Payments on derivative instruments with other-than-insignificant financing elements	(7,125)	(8,270)
Capital contributions from noncontrolling interests	0	9,803
Other, net	(6,600)	(2,759)
Net cash used in financing activities	(199,632)	(192,701)
Cash and cash equivalents (including cash and cash equivalents of discontinued operations):
(Decrease) increase in cash and cash equivalents	(25,562)	(32,521)
Balance, beginning of period	122,702	137,621
Balance, end of period	97,140	105,100
Supplemental cash flow disclosures:
Cash paid for interest	100,617	103,461
Capital expenditures incurred but not yet paid	$ 20,081	$ 23,339